Antoni Bayés-Genís

Insuficiencia Cardiaca y Regeneración Cardiaca (ICREC) Research Program, Health Science Research Institute Germans Trias i Pujol

Affiliated withHealth Science Research Institute Germans Trias i Pujol Germans Trias i Pujol University Hospital Universitat Autònoma de Barcelona

Research Area

Bioengineering

Biography

Antoni Bayés-Genís has not added Biography.
If you are Antoni Bayés-Genís and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 20	2019

Other Publications

Article	Year
Decoding empagliflozin's molecular mechanism of action in heart failure with preserved ejection fraction using artificial intelligence. Scientific reports\| PubMed ID: 34103605	2021
Long COVID-19 and microvascular disease-related angina. Revista espanola de cardiologia (English ed.)\| PubMed ID: 34824040	2022
Circulating linoleic acid at the time of myocardial infarction and risk of primary ventricular fibrillation. Scientific reports\| PubMed ID: 35288655	2022
Circulating virome and inflammatory proteome in patients with ST-elevation myocardial infarction and primary ventricular fibrillation. Scientific reports\| PubMed ID: 35552514	2022
Endomyocardial biopsy in myocarditis: need for proper tissue characterization to keep it alive and kicking. Revista espanola de cardiologia (English ed.)\| PubMed ID: 35697631	2022
Biomarkers of preclinical ventricular dysfunction in type 2 diabetes mellitus. Revista espanola de cardiologia (English ed.)\| PubMed ID: 35787949	2023
Relationship of Circulating Vegetable Omega-3 to Prognosis in Patients With Heart Failure. Journal of the American College of Cardiology\| PubMed ID: 36302588	2022
Diabetes and NT-proBNP: Partners in crime. Diabetes research and clinical practice\| PubMed ID: 36410560	2022
Sudden Cardiac Death in Heart Failure: A 20-Year Perspective From a Mediterranean Cohort. Journal of cardiac failure\| PubMed ID: 36521725	2023
Is Dapagliflozin a Cardiac Anti-Aging Drug? JACC. Heart failure\| PubMed ID: 36647928	2023
Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI. Revista espanola de cardiologia (English ed.)\| PubMed ID: 37105412	2023
SGLT2i and loop diuretic withdrawal or downtitration in heart failure. Revista espanola de cardiologia (English ed.)\| PubMed ID: 37331585	2023
CA125 for Fluid Overload Monitoring: A New Life for an Old Tool. Journal of the American College of Cardiology\| PubMed ID: 37407114	2023
Trajectories of Kidney Function in Heart Failure Over a 15-Year Follow-Up: Clinical Profiling and Mortality. JACC. Heart failure\| PubMed ID: 38430086	2024
Implantation of a double allogeneic human engineered tissue graft on damaged heart: insights from the PERISCOPE phase I clinical trial. EBioMedicine\| PubMed ID: 38490102	2024
Pre-Heart Failure, Heart Stress, and Subclinical Heart Failure: Bridging Heart Health and Heart Failure. JACC. Heart failure\| PubMed ID: 38703158	2024
NT-proBNP: Lower Is Always Better-Even in HFpEF. JACC. Heart failure\| PubMed ID: 39023489	2024
Validation of 2 clinical scores for transthyretin amyloid cardiomyopathy in a Mediterranean cohort of patients at risk. Revista espanola de cardiologia (English ed.)\| PubMed ID: 39442794	2025
Elevated NT-proBNP in Heart Failure and CKD: A Genuine Red Flag for Worse Prognosis-Not a False Positive. JACC. Heart failure\| PubMed ID: 39779182	2025
Long-term trajectory of estimated glomerular filtration rate in ambulatory patients with type 2 diabetes and heart failure: clinical insights and prognostic implications. Cardiovascular diabetology\| PubMed ID: 40045364	2025